Pyridoxine treatment of vincristine-induced cranial polyneuropathy in an adult patient with acute lymphocytic leukemia: Case report and review of the literature

Leukemia Research

Volumn 34, Issue 8, 2010, Pages

  Ngamphaiboon, Nuttapong ^a   Sweeney, Richard ^a   Wetzler, Meir ^a   Wang, Eunice S ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; DOXORUBICIN; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; PYRIDOSTIGMINE; PYRIDOXINE; TIOGUANINE; VINCRISTINE;

ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; BONE MARROW BIOPSY; CANCER CHEMOTHERAPY; CANCER REGRESSION; CASE REPORT; CLINICAL TRIAL; CRANIAL NEUROPATHY; DRUG DOSE REGIMEN; DRUG EFFICACY; DYSARTHRIA; DYSPHAGIA; ELECTROENCEPHALOGRAPHY; FACIAL NERVE INJURY; FASCICULATION; HIGH RISK PATIENT; HOSPITAL DISCHARGE; HUMAN; HUMAN TISSUE; HYPOGLOSSAL NERVE DISEASE; LETTER; LUMBAR PUNCTURE; MAINTENANCE THERAPY; MALE; MOUTH DISCOMFORT; NEPHROBLASTOMA; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIPHERAL NEUROPATHY; PHASE 2 CLINICAL TRIAL; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SARCOMA; TOTAL PARENTERAL NUTRITION; TREATMENT DURATION;

ADULT; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CRANIAL NERVE DISEASES; HUMANS; MALE; POLYNEUROPATHIES; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PYRIDOXINE; TREATMENT OUTCOME; VINCRISTINE; VITAMIN B COMPLEX; YOUNG ADULT;

EID: 77953620465     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2010.01.026     Document Type: Letter

References (21)

1. Moress G.R., D'Agostino A.N., Jarcho L.W. Neuropathy in lymphoblastic leukemia treated with vincristine. Arch Neurol 1967, 16:377-384.
2. Donoso J.A., Green L.S., Heller-Bettinger I.E., Samson F.E. Action of the vinca alkaloids vincristine, vinblastine, and desacetyl vinblastine amide on axonal fibrillar organelles in vitro. Cancer Res 1977, 37:1401-1407.
3. McLeod J.G., Penny R. Vincristine neuropathy: an electrophysiological and histological study. J Neurol Neurosurg Psychiatry 1969, 32:297-304.
4. Casey E.B., Fullerton P.M., Jelliffe A.W. Vincristine neurotoxicity: a clinical and electrophysiological study of eighteen patients. Clin Sci 1970, 38:23-24.
5. Jackson D.V., Sethi V.S., Spurr C.L., McWhorter J.M. Pharmacokinetics of vincristine in the cerebrospinal fluid of humans. Cancer Res 1981, 41:1466-1468.
6. Wheeler J.S., Siroky M.B., Bell R., Babayan R.K. Vincristine-induced bladder neuropathy. J Urol 1983, 130:342-343.
7. Wang W.S., Chiou T.J., Liu J.H., Fan F.S., Yen C.C., Chen P.M. Vincristine-induced dysphagia suggesting esophageal motor dysfunction: a case report. Jpn J Clin Oncol 2000, 30:515-518.
8. Gilliland P., Holguin M. Phrenic nerve paralysis due to vincristine. Leuk Lymphoma 2007, 48:2452-2453.
9. Annino D.J., MacArthur C.J., Friedman E.M. Vincristine-induced recurrent laryngeal nerve paralysis. Laryngoscope 1992, 102:1260-1262.
10. Lash S.C., Williams C.P., Marsh C.S., Crithchley C., Hodgkins P.R., Mackie E.J. Acute sixth-nerve palsy after vincristine therapy. J AAPOS 2004, 8:67-68.
11. Bay A., Yilmaz C., Yilmaz N., Oner A.F. Vincristine induced cranial polyneuropathy. Indian J Pediatr 2006, 73:531-533.
12. Ozyurek H., Turker H., Akbalik M., Bayrak A.O., Ince H., Duru F. Pyridoxine and pyridostigmine treatment in vincristine-induced neuropathy. Pediatr Hematol Oncol 2007, 24:447-452.
13. Duman O., Tezcan G., Hazar V. Treatment of vincristine-induced cranial polyneuropathy. J Pediatr Hematol Oncol 2005, 27:241-242.
14. Müller L., Kramm C.M., Tenenbaum T., Wessalowski R., Göbel U. Treatment of vincristine-induced bilateral ptosis with pyridoxine and pyridostigmine. Pediatr Blood Cancer 2004, 42:287-288.
15. Dejan S., Dragana B., Ivana P., Borivoje B., Marko P. Vincristine induced unilateral ptosis. J Pediatr Hematol Oncol 2009, 31:463.
16. Stock W., La M., Sanford B., Bloomfield C.D., Vardiman J.W., Gaynon P., et al. What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies. Blood 2008, 112:1646-1654.
17. Carlson H.B., Anthony E.M., Russell W.F., Middlebrook G. Prophylaxis of isoniazid neuropathy with pyridoxine. N Engl J Med 1956, 255:119-122.
18. Mandel W. Pyridoxine and the isoniazid-induced neuropathy. Dis Chest 1959, 36:293-296.
19. Jackson D., Long T., Rich C., Rardin D., McMahan R., Case D., et al. Pyridoxine modification of vincristine toxicity (Abst). Proc Am Assoc Cancer Res 1984, 25:313. [Presented at the seventy-fifth annual meeting of the American Association for Cancer Research, Toronto, Ontario, Canada, May, 1984].
20. Jackson D.V., Pope E.K., McMahan R.A., Cooper M.R., Atkins J.N., Callahan R.D., et al. Clinical trial of pyridoxine to reduce vincristine neurotoxicity. J Neurooncol 1986, 4:37-41.
21. Schaumburg H., Kaplan J., Windebank A., Vick N., Rasmus S., Pleasure D., et al. Sensory neuropathy from pyridoxine abuse. A new megavitamin syndrome. N Engl J Med 1983, 309:445-448.